Daniella Beckman
Directeur Financier/CFO chez TANGO THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2024
Postes actifs de Daniella Beckman
Sociétés | Poste | Début | Fin |
---|---|---|---|
VOR BIOPHARMA INC. | Directeur/Membre du Conseil | 16/07/2020 | - |
Independent Dir/Board Member | 16/07/2020 | - | |
TANGO THERAPEUTICS, INC. | Directeur Financier/CFO | 01/10/2016 | - |
BLUEPRINT MEDICINES CORPORATION | Directeur/Membre du Conseil | 08/12/2021 | - |
Independent Dir/Board Member | 08/12/2021 | - | |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 01/09/2019 | - |
Historique de carrière de Daniella Beckman
Anciens postes connus de Daniella Beckman
Sociétés | Poste | Début | Fin |
---|---|---|---|
501 ACQU | Directeur/Membre du Conseil | 01/10/2020 | 01/01/2022 |
Independent Dir/Board Member | 01/10/2020 | 01/01/2022 | |
TRANSLATE BIO, INC. | Directeur/Membre du Conseil | 04/10/2017 | 14/09/2021 |
Independent Dir/Board Member | 04/10/2017 | 14/09/2021 | |
NEON THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2015 | 01/09/2019 |
Beckman Consulting LLC
Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Beckman Consulting LLC provides consulting services. The private company is based in Boston. | Directeur Financier/CFO | 01/11/2015 | 01/09/2019 |
IDENIX PHARMACEUTICALS INC | Directeur/Membre du Conseil | 01/01/2011 | 01/08/2014 |
Directeur Financier/CFO | 01/01/2011 | 01/08/2014 | |
Treasurer | 01/01/2011 | 01/08/2014 |
Formation de Daniella Beckman
Boston University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
Director/Board Member | 5 |
Director of Finance/CFO | 5 |
Independent Dir/Board Member | 4 |
Sectorielle
Health Technology | 8 |
Consumer Services | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
VOR BIOPHARMA INC. | Health Technology |
TANGO THERAPEUTICS, INC. | Health Technology |
BLUEPRINT MEDICINES CORPORATION | Health Technology |
Entreprise privées | 6 |
---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Translate Bio, Inc.
Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
BioNTech US, Inc.
BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
5:01 Acquisition Corp.
5:01 Acquisition Corp. Financial ConglomeratesFinance 5:01 Acquisition Corp. is a blank check emerging growth company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 31, 2020 and is headquartered in San Francisco, CA. | Finance |
Beckman Consulting LLC
Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Beckman Consulting LLC provides consulting services. The private company is based in Boston. | Commercial Services |
- Bourse
- Insiders
- Daniella Beckman
- Expérience